Supernus Pharmaceuticals Announces Resignation Of Board Member
Published: Dec 27, 2013
ROCKVILLE, Md., Dec. 24, 2013 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, announced today that Michael Bigham, a General Partner at Abingworth has resigned from the company's board of directors, effective December 23, 2013.
Help employers find you! Check out all the jobs and post your resume.